Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline for Treatment of Serious Infection Due to Rapidly Growing Mycobacteria
NCT00600600Phase 2Completed
- Sponsor
- The University of Texas Health Science Center at Tyler
- Start
- Apr 2002
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tigecycline in Mycobacterium abscessus lung disease, rapidly growing mycobacterial lung disease, sponsored by The University of Texas Health Science Center at Tyler. Started Apr 2002; status: completed.
02
Drugs
tigecycline
03
Conditions
Mycobacterium abscessus lung diseaserapidly growing mycobacterial lung disease
Beyond the preview
Go deeper on NCT00600600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600600.